Cargando…

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines

In the course of isolating the attenuated Japanese encephalitis vaccine SA14-14-2, two attenuated strains SA14-9-7 and SA14-5-3 were also obtained that elicited low antibody responses in humans (<10% and 62%, respectively) and exerted much weaker immune protection in animal challenge experiments....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuhua, Fu, Yin, Liu, Xinyu, Yang, Huiqiang, Yu, Yongxin, Jia, Lili, Li, Xuguang, Farnsworth, Aaron, Wang, Junzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661631/ https://www.ncbi.nlm.nih.gov/pubmed/29263913 http://dx.doi.org/10.1038/sigtrans.2017.5

Ejemplares similares

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
por: Liu, Xinyu, et al.
Publicado: (2018)

Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity
por: Davis, Emily H., et al.
Publicado: (2021)

Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
por: Yang, Jian, et al.
Publicado: (2017)

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity
por: Qi, Zhongbing, et al.
Publicado: (2023)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
por: Jia, Na, et al.
Publicado: (2011)

Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine
por: Hills, Susan L., et al.
Publicado: (2021)

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
por: Kwon, Hyo Jin, et al.
Publicado: (2015)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
por: Bonaparte, Matthew, et al.
Publicado: (2014)

The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus
por: Yang, Jian, et al.
Publicado: (2017)

Accidental acquisition of a rescued Japanese encephalitis virus with unspliced introns in the viral genome when using an intron-based stabilization approach
por: Huang, Ying, et al.
Publicado: (2023)

Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability
por: Wang, Xiangxi, et al.
Publicado: (2017)

Japanese Encephalitis, Singapore
por: Koh, Yin-Ling, et al.
Publicado: (2006)

Molecular and clinical relationship between live‐attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
por: He, Dan, et al.
Publicado: (2018)

Corilagin Attenuates the Parkinsonismin Japanese Encephalitis Virus Induced Parkinsonism
por: Yanbing, Ding, et al.
Publicado: (2018)

STUDIES ON THE BIOCHEMICAL, BIOPHYSICAL, AND IMMUNOGENIC PROPERTIES OF JAPANESE B TYPE ENCEPHALITIS VIRUS AND VACCINES
por: Duffy, Carl E., et al.
Publicado: (1945)

USP1-Associated Factor 1 Modulates Japanese Encephalitis Virus Replication by Governing Autophagy and Interferon-Stimulated Genes
por: Xing, Jinchao, et al.
Publicado: (2023)

Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV
por: Tajima, Shigeru, et al.
Publicado: (2021)

Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2019)

Effectiveness of Live-Attenuated Genotype III Japanese Encephalitis Viral Vaccine against Circulating Genotype I Viruses in Swine
por: Fan, Yi-Chin, et al.
Publicado: (2022)

A Serosurvey of Japanese Encephalitis Virus in Monkeys and Humans Living in Proximity in Thailand
por: Lakhotia, Divya, et al.
Publicado: (2023)

Japanese Encephalitis, Tibet, China
por: Li, Yi-Xing, et al.
Publicado: (2011)

miR-124 attenuates Japanese encephalitis virus replication by targeting DNM2
por: Yang, Songbai, et al.
Publicado: (2016)

Safety of Japanese encephalitis vaccines
por: Hu, Ya-Li, et al.
Publicado: (2021)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
por: Chanthavanich, Pornthep, et al.
Publicado: (2018)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020)

Japanese B Encephalitis
por: Mehta, Anita, et al.
Publicado: (2021)

Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model
por: Li, Yize, et al.
Publicado: (2012)

An outbreak of Japanese encephalitis caused by genotype Ib Japanese encephalitis virus in China, 2018: A laboratory and field investigation
por: Liu, Wenjing, et al.
Publicado: (2020)

Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
por: Chan, Kuan Rong, et al.
Publicado: (2016)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
por: Bouckenooghe, Alain, et al.
Publicado: (2018)

High Incidence of Japanese Encephalitis, Southern China
por: Feng, Yun, et al.
Publicado: (2013)

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
por: Bielefeldt-Ohmann, Helle, et al.
Publicado: (2014)

Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III
por: Fan, Yi-Chin, et al.
Publicado: (2015)

Japanese Encephalitis Outbreak, Yuncheng, China, 2006
por: Wang, Li-Hua, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_oqfltqq0lsnkfesenr6ll9j0ad